How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
FORT LAUDERDALE , Fla., Jan. 3 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) announced today that M Squared Associates of Washington, DC , has been selected by IDSI to audit and monitor the company's clinical trials.
"We are very pleased to have M Squared as our clinical trial monitor," stated Deborah O'Brien, Senior Vice President, IDSI. "It is highly important to us that we have exacting standards for following protocol and ensuring that the data is properly collected. With everything that M Squared has to offer, we look forward to working with them."
M Squared Associates will provide both expertise in clinical study management as well as experience with the FDA. The company's senior staff includes past executive managers from both Fortune 500 and early stage medical device companies, as well as past managers from the FDA Center for Devices and Radiological Health.
"We're very proud to be part of the team for the CTLM clinical study," said Marie Marlow , President and CEO of M Squared Associates. "We consider it a compliment when a company such as Imaging Diagnostic Systems chooses M Squared Associates as its contract research organization (CRO) partner. The CTLM system could benefit thousands of women with a potential diagnosis of breast cancer, so it's important to me both personally and professionally that this clinical study is well-run and supports a quick FDA approval."